- Home
- ROIV vs LAMR Comparison
ROIV vs LAMR Comparison
Compare ROIV & LAMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | LAMR |
|---|---|---|
| Founded | 2014 | 1902 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 13.1B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | ROIV | LAMR |
|---|---|---|
| Price | $21.70 | $126.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $21.94 | ★ $131.75 |
| AVG Volume (30 Days) | ★ 6.7M | 460.1K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 5.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.24 |
| Revenue | $20,329,000.00 | ★ $2,253,062,000.00 |
| Revenue This Year | N/A | $4.38 |
| Revenue Next Year | $376.94 | $4.46 |
| P/E Ratio | ★ N/A | $30.18 |
| Revenue Growth | N/A | ★ 2.98 |
| 52 Week Low | $8.73 | $99.84 |
| 52 Week High | $22.45 | $134.63 |
Technical Indicators
Market Signals| Indicator | ROIV | LAMR |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 43.01 |
| Support Level | $20.14 | $129.21 |
| Resistance Level | $21.48 | $134.14 |
| Average True Range (ATR) | 0.71 | 2.20 |
| MACD | 0.00 | -0.90 |
| Stochastic Oscillator | 65.96 | 0.36 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About LAMR Lamar Advertising Company
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.